In modified intention-to-treat analysis, time to linkage to care significantly less for people with HIV in intervention group ...

Frank Gupton, CEO of Medicines for All, said he hopes that will lead to production facilities closer to those high need areas like sub-Saharan Africa.

Zimbabwe clears key hurdle for energy project Zimbabwe’s energy sector has reached a major milestone following the successful ...

Coalition of charities and MPs have signed a letter from Geordie Greig, editor-in-chief of The Independent, appealing to the ...

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

Some local officials want to hamper needle exchange programs that public health officials say are crucial to reducing the spread of blood-borne diseases.

Introduction Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy, but its impact is limited by low uptake ...

According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a glimpse at the future of human health. A colorized transmission electron ...

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...

A 24-month study in Kenya, Uganda and South Africa has found that injectable HIV treatment, Cabotegravir/Rilpivirine, also known in medical terms as CAB LA + RPV LA ...